Enlivex Therapeutics Ltd. Quarterly Common Stock, Par or Stated Value Per Share in USD/shares from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: ILS/shares and USD/shares
Description
Face amount or stated value per share of common stock.
Summary
Enlivex Therapeutics Ltd. quarterly Common Stock, Par or Stated Value Per Share history and growth rate from Q4 2017 to Q2 2024.
  • Enlivex Therapeutics Ltd. Common Stock, Par or Stated Value Per Share for the quarter ending June 30, 2024 was 0.4 USD/shares.
Common Stock, Par or Stated Value Per Share, Quarterly (USD/shares)
Common Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $0.40 Jun 30, 2024 6-K 2024-08-30
Q4 2023 $0.40 Dec 31, 2023 6-K 2024-08-30
Q2 2021 $0.12 +$0.01 +9.09% Jun 30, 2021 6-K 2021-08-06
Q4 2020 $0.12 +$0.01 +9.09% Dec 31, 2020 6-K 2021-08-06
Q2 2020 $0.11 Jun 30, 2020 6-K/A 2020-10-13
Q1 2020 $9.00 Mar 5, 2020 6-K/A 2020-10-13
Q4 2019 $0.11 $0 0% Dec 31, 2019 20-F 2021-04-30
Q4 2018 $0.11 $0 0% Dec 31, 2018 20-F 2020-04-30
Q4 2017 $0.11 Dec 31, 2017 20-F 2019-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.